Your browser doesn't support javascript.
loading
Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure.
Xu, Pengfei; Xi, Yue; Wang, Pengcheng; Luka, Zigmund; Xu, Meishu; Tung, Hung-Chun; Wang, Jingyuan; Ren, Songrong; Feng, Dechun; Gao, Bin; Singhi, Aatur D; Monga, Satdarshan P; York, John D; Ma, Xiaochao; Huang, Zhiying; Xie, Wen.
Afiliación
  • Xu P; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Xi Y; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Wang P; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Luka Z; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee.
  • Xu M; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Tung HC; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Wang J; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Ren S; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Feng D; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
  • Gao B; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
  • Singhi AD; Department of Pathology and Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Monga SP; Department of Pathology and Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • York JD; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee.
  • Ma X; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Huang Z; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Xie W; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: wex6@pitt.edu.
Gastroenterology ; 162(4): 1226-1241, 2022 04.
Article en En | MEDLINE | ID: mdl-34954226
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fallo Hepático Agudo / Enfermedad Hepática Inducida por Sustancias y Drogas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fallo Hepático Agudo / Enfermedad Hepática Inducida por Sustancias y Drogas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos